SCHEMBL1498746

SCHEMBL1498746

Cn1c(=O)ccc2ccc3ccc(Cl)nc3c21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRPF1 P55201 4/20 0.39
CA12 O43570 1/20 0.39
BRD4 O60885 1/20 0.39
CA9 Q16790 1/20 0.39
KAT2B Q92831 1/20 0.39
BRD9 Q9H8M2 1/20 0.39
SLC40A1 Q9NP59 3/20 0.32
KDM4E B2RXH2 3/20 0.31
ALDH1A1 P00352 3/20 0.31
HPGD P15428 2/20 0.31
GLA P06280 1/20 0.31
GAA P10253 1/20 0.31
CDK4 P11802 1/20 0.31
CCND1 P24385 1/20 0.31
CCND2 P30279 1/20 0.31
CCND3 P30281 1/20 0.31
PTGER4 P35408 1/20 0.31
PRMT5 O14744 1/20 0.31
ADORA1 P30542 1/20 0.31
PIM1 P11309 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30251020 1.00 BRPF1 (0.39) BRPF1CA12BRD4CA9KAT2B
SCHEMBL1498659 0.79 BRPF1 (0.39) BRPF1CA12BRD4CA9KAT2B
SCHEMBL5364876 0.76 CDK4 (0.43) BRPF1CA12BRD4CA9KAT2B
SCHEMBL30250982 0.75 ADORA1 (0.43) BRPF1CA12BRD4CA9KAT2B
SCHEMBL809908 0.74 LMNA (0.50) BRPF1CA12BRD4CA9KAT2B
SCHEMBL11286560 0.70 BRPF1 (0.50) BRPF1CA12BRD4CA9KAT2B
SCHEMBL20975457 0.69 MIF (0.44) BRPF1BRD4BRD9SLC40A1KDM4E
SCHEMBL29533844 0.68 CCR1 (0.43) SLC40A1KDM4EPTGER4PIM1PIM2
SCHEMBL557084 0.68 CCR1 (0.43) SLC40A1KDM4EPTGER4PIM1PIM2
SCHEMBL24130871 0.67 NQO2 (0.46) BRPF1CA12BRD4CA9KAT2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9187690-B2 Rare earth metal complex having phenanthroline compound as ligand B.R.A.H.M.S. GMBH (DE) 2015-11-17 US disclosed
US-9187690-B2 Rare earth metal complex having phenanthroline compound as ligand B.R.A.H.M.S. GMBH (DE) 2015-11-17 US disclosed
US-9187690-B2 Rare earth metal complex having phenanthroline compound as ligand B.R.A.H.M.S. GMBH (DE) 2015-11-17 US disclosed
EP-2683725-B1 RARE EARTH METAL COMPLEX HAVING PHENANTHROLINE COMPOUND AS LIGAND BRAHMS GMBH (DE) 2015-08-26 EP disclosed
EP-2683725-B1 RARE EARTH METAL COMPLEX HAVING PHENANTHROLINE COMPOUND AS LIGAND BRAHMS GMBH (DE) 2015-08-26 EP disclosed
EP-2477986-B1 PHENANTHROLINE DERIVATIVES AND THEIR USE AS LIGANDS BRAHMS GMBH (DE) 2014-11-12 EP disclosed
US-20140058073-A1 RARE EARTH METAL COMPLEX HAVING PHENANTHROLINE COMPOUND AS LIGAND B.R.A.H.M.S. GMBH (DE) 2014-02-27 US disclosed
US-20140058073-A1 RARE EARTH METAL COMPLEX HAVING PHENANTHROLINE COMPOUND AS LIGAND B.R.A.H.M.S. GMBH (DE) 2014-02-27 US disclosed
US-20140058073-A1 RARE EARTH METAL COMPLEX HAVING PHENANTHROLINE COMPOUND AS LIGAND B.R.A.H.M.S. GMBH (DE) 2014-02-27 US disclosed
US-8648194-B2 Compounds having phenanthroline structure B.R.A.H.M.S GMBH (DE) 2014-02-11 US disclosed
US-8648194-B2 Compounds having phenanthroline structure B.R.A.H.M.S GMBH (DE) 2014-02-11 US disclosed
US-8648194-B2 Compounds having phenanthroline structure B.R.A.H.M.S GMBH (DE) 2014-02-11 US disclosed
EP-2683725-A1 RARE EARTH METAL COMPLEX HAVING PHENANTHROLINE COMPOUND AS LIGAND B.R.A.H.M.S GmbH (DE) 2014-01-15 EP disclosed
US-20120238748-A1 NOVEL COMPOUNDS HAVING PHENANTHROLINE STRUCTURE B.R.A.H.M.S GMBH (DE) 2012-09-20 US disclosed
WO-2012124310-A1 RARE EARTH METAL COMPLEX HAVING PHENANTHROLINE COMPOUND AS LIGAND B.R.A.H.M.S GMBH (DE) 2012-09-20 WO disclosed
US-20120238748-A1 NOVEL COMPOUNDS HAVING PHENANTHROLINE STRUCTURE B.R.A.H.M.S GMBH (DE) 2012-09-20 US disclosed
US-20120238748-A1 NOVEL COMPOUNDS HAVING PHENANTHROLINE STRUCTURE B.R.A.H.M.S GMBH (DE) 2012-09-20 US disclosed
WO-2012124310-A1 RARE EARTH METAL COMPLEX HAVING PHENANTHROLINE COMPOUND AS LIGAND B.R.A.H.M.S GMBH (DE) 2012-09-20 WO disclosed
EP-2477986-A1 PHENANTHROLINE DERIVATIVES AND THEIR USE AS LIGANDS B.R.A.H.M.S GmbH (DE) 2012-07-25 EP disclosed
WO-2011030566-A1 PHENANTHROLINE DERIVATIVES AND THEIR USE AS LIGANDS EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-03-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120238748-A1 NOVEL COMPOUNDS HAVING PHENANTHROLINE STRUCTURE PAH, BPTF, HDAC1 BRPF1 797/4885CA12 1573/4885BRD4 22/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.